Supercharge Your Innovation With Domain-Expert AI Agents!

Synthesis method of hydroxychloroquine sulfate

A technology of hydroxychloroquine sulfate and sulfuric acid, applied in the direction of organic chemistry, can solve the problems of cumbersome operation, unfriendly environment, long reaction time, etc., and achieve the effect of simple overall process, strong operability and short reaction steps

Active Publication Date: 2021-06-08
福建海西新药创制股份有限公司
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] This method has three obvious disadvantages: 1. A large amount of phenol is used as a reaction solvent. Because phenol is toxic and corrosive, it is harmful to the human body, and the waste liquid containing phenol increases the difficulty of waste disposal, which is extremely unfriendly to the environment; 2. Phenol is solid (42 DEG C of melting point) at normal temperature, needs heating and dissolving during use and can carry out feeding, and operation is loaded down with trivial details when enlarging production; Three, adopted hydroxychloroquine side chain (formula II) to make raw material, and this side chain existing preparation The route steps are cumbersome and expensive, which is not conducive to the control of product costs
[0012] This method has two obvious deficiencies: one, adopted hydroxychloroquine side chain (formula II) to make raw material, and the existing preparation route step of this side chain is loaded down with trivial details, the cost is expensive, is unfavorable for the control of product cost; Two, reaction time is up to 20 -24h, not only increases the production cost, but also easily leads to the increase of impurity content
[0015] This method has three obvious defects: one, adopted hydroxychloroquine side chain (formula II) as raw material, and the existing preparation route step of this side chain is loaded down with trivial details, and the cost is expensive, is unfavorable for the control of product cost; Two, adopt pressurized condition to react , has high requirements for equipment, and there is a certain risk in scale-up production; 3. The use of chloroform, a highly toxic class II solvent, as the extraction solvent is extremely harmful to humans and the environment
[0021] This method is the same as the method disclosed in the patent WO2019165337A1. There are also intermediates that do not absorb ultraviolet rays and are mostly liquids. It is difficult to detect and purify. At the same time, the reaction is carried out under pressurized conditions, which requires high equipment. There is a certain risk in scale-up production. The finished product high cost and other disadvantages
[0022] In summary, the existing technology for preparing hydroxychloroquine sulfate has high cost of raw materials, long reaction time, large energy consumption and large environmental pollution. Therefore, it is urgent to find an environmentally friendly, cost-controllable, industrialized New Technology

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis method of hydroxychloroquine sulfate
  • Synthesis method of hydroxychloroquine sulfate
  • Synthesis method of hydroxychloroquine sulfate

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0041] The preparation of embodiment 1 formula III compound

[0042]

[0043] At room temperature, the formula 4,7-dichloroquinoline (19.8g, 100.0mmol), 5-methyl-2-pyrrolidone (14.9g, 150.0mmol), 4,5-bisdiphenylphosphine-9,9 -Dimethylxanthene (578mg, 1.0mmol), palladium acetate (224 mg, 1.0mmol) and cesium carbonate (48.8g, 150.0mmol) were mixed in 1,4-dioxane (150ml), nitrogen replacement Three times, under the protection of nitrogen, the temperature was raised to reflux and stirred. It was detected by TLC that the raw materials were consumed completely, the reaction was stopped, and the temperature was cooled to room temperature. Add ethyl acetate (300ml) and water (300ml) into the system, stir for a while, separate the layers, extract the aqueous phase with ethyl acetate (150ml) again, and combine the organic phases. The organic phase was washed successively with water (200ml) and saturated sodium chloride (200ml), and concentrated to dryness under reduced pressure to ...

Embodiment 4

[0048] The preparation of embodiment 4 formula IV compound

[0049]

[0050] At room temperature, the compound of formula III (2.6g, 10.0mmol) and N-ethylethanolamine (4.5g, 50.0mmol) were mixed, heated to 80°C and stirred. It was detected by TLC that the raw materials were completely consumed, the reaction was stopped, and the temperature was cooled to room temperature to obtain an orange mucus. Recrystallized from isopropanol (4ml) and n-hexane (10ml) to obtain 2.2g of a yellow solid with a yield of 63%, which is the compound of formula IV.

Embodiment 5

[0051] The preparation of embodiment 5 formula IV compound

[0052] At room temperature, aluminum trichloride (1.7g, 13.0mmol) was mixed with dichloromethane (20ml), and the temperature was lowered to 0°C under nitrogen protection; the compound of formula III (2.6g, 10.0mmol) and N-ethyl Add ethanolamine (2.7 g, 25.0 mmol) into the above system, and keep stirring at an internal temperature of 0-5°C. TLC detects that the raw materials are consumed completely, quench the reaction with water (30 ml), adjust the system pH=7 to 8 with aqueous sodium hydroxide solution (1N), stir for a while, separate the layers, discard the aqueous layer, and concentrate the organic layer to dryness under reduced pressure. Get orange slime. Recrystallized from isopropanol (4ml) and n-hexane (10ml) to obtain 2.6g of a yellow solid with a yield of 74%, which is the compound of formula IV.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a preparation method of hydroxychloroquine sulfate 2-((4-((7-chloro-4-quinolyl)amino)amyl)ethylamino)-ethanol sulfate. The method provided by the invention has the advantages of cheap and easily available raw materials, short reaction steps, high yield, simple overall process, strong operability, environmental friendliness and the like, reduces the cost, and is suitable for large-scale industrial production.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to the preparation of hydroxychloroquine sulfate for treating malaria, rheumatoid arthritis and systemic lupus erythematosus. Background technique [0002] Hydroxychloroquine is a 4-aminoquinone compound with a chemical name of 2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)-ethanol, and its chemical structure is as follows: [0003] [0004] In 1951, Winthrop successfully developed hydroxychloroquine for the treatment of malaria, and in 1955 for the treatment of systemic lupus erythematosus. In 1998, the US FDA approved hydroxychloroquine for the treatment of rheumatoid arthritis and lupus erythematosus. Compared with other similar drugs, it has an advantage in terms of safety. It can not only improve the symptoms of arthritis in patients, but also resist oxidation and blood lipids, avoid a large number of platelet aggregation, reduce the blood sugar level of patients, a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D215/46
CPCC07D215/46
Inventor 连昕王如勇赵如薇冯岩康心汕
Owner 福建海西新药创制股份有限公司
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More